NEW YORK (GenomeWeb) – Piper Jaffray has downgraded shares of Quidel to a Neutral rating from Overweight, citing the "limited upside" the company is likely to see in the 2016-2017 flu season.
NEW YORK (GenomeWeb) – Piper Jaffray has downgraded shares of Quidel to a Neutral rating from Overweight, citing the "limited upside" the company is likely to see in the 2016-2017 flu season.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.